RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/9300671http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/9300671http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/9300671http://www.w3.org/2000/01/rdf-schema#comment"Chemokines are a group of small, homologous proteins that regulate leukocyte migration, hemopoiesis, and HIV-1 absorption. We report here the cloning and characterization of a novel murine and human C-C chemokine termed Exodus-2 for its similarity to Exodus-1/MIP-3alpha/LARC, and its chemotactic ability. This novel chemokine has a unique 36 or 37 (murine and human, respectively) amino acid carboxyl-terminal extension not seen in any other chemokine family member. Purified recombinant Exodus-2 was found to have two activities classically associated with chemokines: inhibiting hemopoiesis and stimulating chemotaxis. However, Exodus-2 also had unusual characteristics for C-C chemokines. It selectively stimulated the chemotaxis of T-lymphocytes and was preferentially expressed in lymph node tissue. The combination of these characteristics may be a functional correlate for the unique carboxyl-terminal structure of Exodus-2."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Kim C.H."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Kim C.H."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Broxmeyer H.E."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Broxmeyer H.E."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Cooper S."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Cooper S."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Hromas R."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Hromas R."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Fife K."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Fife K."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Klemsz M."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Klemsz M."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Krathwohl M."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Krathwohl M."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Schnizlein-Bick C."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/author"Schnizlein-Bick C."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/date"1997"xsd:gYear
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/date"1997"xsd:gYear
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/name"J. Immunol."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/name"J. Immunol."xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/pages"2554-2558"xsd:string
http://purl.uniprot.org/citations/9300671http://purl.uniprot.org/core/pages"2554-2558"xsd:string